Catalyst Wire Dossier Catalyst Wire Dossier

5% KOH solution

· Infectopharm Arzneimittel GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 5% KOH solution, covering 2024-03-05 to 2024-03-05. Get the full timeline:

Most recent: Clinical Trial Update: 5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis [Phase 3]

See pricing